Longitudinal analysis of chronic allograft nephropathy: Clinicopathologic correlations

Kidney International

Volumn 68, Issue SUPPL. 99, 2005, Pages

  Chapman, Jeremy R ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Calcineurin inhibitors; Chronic allograft nephropathy; Nephrotoxicity; Renal dysfunction; Renal transplant

Indexed keywords

CALCINEURIN INHIBITOR; CALCINEURIN; CREATININE;

CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; FIBROSING ALVEOLITIS; GLOMERULOSCLEROSIS; GRAFT FAILURE; GRAFT REJECTION; HUMAN; HYALINE DEGENERATION; IMMUNE MEDIATED INJURY; ISCHEMIA; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; NEPHROTOXICITY; PRIORITY JOURNAL; RECIPIENT; REPERFUSION INJURY; ALLOTRANSPLANTATION; ARTICLE; BIOPSY; BLOOD; CHRONIC DISEASE; DRUG ANTAGONISM; FIBROSIS; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; IMMUNOLOGY; KIDNEY; KIDNEY DISEASE; LONGITUDINAL STUDY; PANCREAS TRANSPLANTATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK; TIME;

BIOPSY; CALCINEURIN; CHRONIC DISEASE; CREATININE; FIBROSIS; GLOMERULAR FILTRATION RATE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; PANCREAS TRANSPLANTATION; REPERFUSION INJURY; RISK; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33748286715     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.09920.x     Document Type: Conference Paper

References (19)

1. MCDONALD S, EXCELLL (editors): ANZDATA Registry Report 2004, Adelaide, South Australia, Australia and New Zealand Dialysis and Transplant Registry, 2004
2. MEIER-KRIESCHE HU, SCHOLD JD, KAPLAN B: Long term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 4:1289-1295, 2004
3. US RENAL DATA SYSTEM, USRDS 2004 ANNUAL REPORT: Atlas of End-stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2004
4. HUNSICKER LG, BENNETT LE: Acute rejection reduces creatinine clearance at 6 months following renal transplantation but does not affect subsequent slope of Ccr. Transplantation 67:S83, 1999
5. RACUSEN LC, SOLEZ K, COLVIN RB, et al: The Banff 97 working classification of renal allograft pathology. Kidney Int 55:713-723, 1999
6. SOLEZ K: International standardization of criteria for histologic diagnosis of chronic rejection in renal allografts. Clin Transplant 8:345-350, 1994
7. SOLEZ K, AXELSEN RA, BENEDIKTSSON H, et al: International standardization of criteria for the histologic diagnosis of renal allograft rejection:The Banff working classification of kidney transplant pathology. Kidney Int 44:411-422, 1993
8. DEAN DE, KAMATH S, PEDDI VR, et al: A blinded retrospective analysis of renal allograft pathology using the Banff schema: Implications for clinical management. Transplantation 68:642-645, 1999
9. COLVIN RB: Chronic allograft nephropathy. N Engl J Med 349:2288-2290, 2003
10. FURNESS PN, PHILPOTT CM, CHORBADJIAN MT, et al: Protocol biopsy of the stable renal transplant: A multicenter study of methods and complication rates. Transplantation 76:969-973, 2003
11. KUYPERS DR, CHAPMAN JR, O'CONNELL PJ, et al: Predictors of renal transplant histology at three months. Transplantation 67:1222-1227, 1999
12. NANKIVELL BJ, FENTON-LEE CA, KUYPERS DR, et al: Effect of histological damage on long-term kidney transplant outcome. Transplantation 71:515-523, 2001
13. NANKIVELL BJ, BORROWS RJ, FUNG CL-S, et al: The natural history of chronic allograft nephropathy. N Engl J Med 349:2326-2333, 2003
14. NANKIVELL BJ, BORROWS RJ, FUNG CL-S, et al: Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation 78:242-249, 2004
15. NANKIVELL BJ, BORROWS RJ, FUNG CL-S, et al: Delta analysis of post-transplantation tubulointerstitial damage. Transplantation 78:434-441, 2004
16. NANKIVELL BJ, BORROWS RJ, FUNG CL-S, et al: Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology. Transplantation 78:557-565, 2004
17. NANKIVELL BJ, BORROWS RJ, FUNG CL-S, et al: Evolution and pathophysiology of renal-transplant glomerulosclerosis. Transplantation 78:461-468, 2004
18. SOLEZ K, VINCENTI F, FILO R. Histopathological findings from 2-year protocol biopsies from a US multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: A report of the FK506 kidney transplant study group. Transplantation 66:1736-1740, 1998
19. HAMBURGER J CROSNIER J, DORMONT J: Observations in patients with a well tolerated homotransplant kidney: Possibility of a new secondary disease. Ann N Y Acad Sci 120:558-577, 1964